What should guide drug class selection for type 2 diabetes mellitus (DM)?

Updated: Oct 23, 2019
  • Author: Romesh Khardori, MD, PhD, FACP; Chief Editor: George T Griffing, MD  more...
  • Print
Answer

A study by Gross et al found no difference in benefit between drug classes in patients already on metformin and sulfonylurea. The patient's clinical circumstances must guide selection. [146]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!